Technology
Pipeline
Intranasal Naloxone
Intranasal Epinephrine
About us
Contact
News
Investors
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Menu
Technology
Pipeline
Intranasal Naloxone
Intranasal Epinephrine
About us
Contact
News
Investors
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
Address
Yigal Alon 65, Tel Aviv Israel
Email
info@nasuspharma.com
Phone
03-7326616
Have a Question? Write us!
Name
Email
Message
SEND
